<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35158380</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-4413</ISSN><JournalIssue CitedMedium="Internet"><Volume>147</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Deutsche medizinische Wochenschrift (1946)</Title><ISOAbbreviation>Dtsch Med Wochenschr</ISOAbbreviation></Journal><ArticleTitle>[Late neurological consequences of a SARS-CoV-2 infection].</ArticleTitle><Pagination><StartPage>173</StartPage><EndPage>177</EndPage><MedlinePgn>173-177</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/a-1689-6188</ELocationID><Abstract><AbstractText Label="BACKGROUND">Persistent neurological late symptoms of SARS-CoV-2 infection are common and require regular follow-up treatment. In order to establish uniform therapy concepts, it is necessary to evaluate individual therapeutic approaches for long COVID and post-COVID-19 syndrome.</AbstractText><AbstractText Label="ANAMNESE">A 62-year-old patient was admitted to our rehab clinic for follow-up treatment after severe SARS-CoV-2 infection with neurological symptoms. The initially extensive laboratory and imaging investigation did not reveal any organic cause for the sometimes apoplectiform, complex clinical picture, so that the patient was transferred directly to our rehabilitation clinic in the event of everyday restrictions and rollator dependency.</AbstractText><AbstractText Label="EXAMINATION AND FINDINGS">Clinically, there was a reduced general condition and the mood was depressed. Neurological symptoms were gait ataxia, hand tremor, amnesic aphasia and reduced ability to concentrate. PET / CT showed no evidence of tumor or inflammation.</AbstractText><AbstractText Label="THERAPY AND PROGRESS">A multimodal therapy program consisting of physiotherapy and occupational therapy as well as psychological support was carried out. In addition, off-label therapy with oral glucocorticoids and colchicine was initiated. In the course of the disease, there was a clear reduction in all symptoms with little residual hand tremor.</AbstractText><AbstractText Label="CONCLUSIONS">Whole body and brain FDG PET can be helpful in long COVID and post-COVID-19 syndrome patients with neurological symptoms of unknown origin. These patients benefit from systematic rehabilitation. Glucocorticoids and colchicine appear to accelerate symptom reduction. The rehabilitative therapy should be continued on an outpatient basis.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Michler</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Klinik u. Poliklinik f. Nuklearmedizin, Universit&#xe4;tsklinikum Carl Gustav Carus Dresden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dolzhenko</LastName><ForeName>Yuliia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Median Klinik f&#xfc;r Kardiologie Bad Gottleuba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altmann</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Median Klinik f&#xfc;r Kardiologie Bad Gottleuba.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Neurologische Sp&#xe4;tfolgen einer SARS-CoV-2-Infektion.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Dtsch Med Wochenschr</MedlineTA><NlmUniqueID>0006723</NlmUniqueID><ISSNLinking>0012-0472</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009788" MajorTopicYN="N">Occupational Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026741" MajorTopicYN="N">Physical Therapy Modalities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072858" MajorTopicYN="N">Psychosocial Support Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText Label="HINTERGRUND">Anhaltende neurologische Sp&#xe4;tsymptome einer SARS-CoV-2-Infektion sind h&#xe4;ufig und erfordern regelm&#xe4;&#xdf;ig eine Anschlussheilbehandlung. Zur Etablierung einheitlicher Therapiekonzepte ist die Evaluierung individueller Therapieans&#xe4;tze bei Long- und Post-Covid-Syndrom erforderlich.</AbstractText><AbstractText Label="ANAMNESE">Ein 62-j&#xe4;hriger Patient wurde nach schwerem Verlauf einer SARS-CoV-2-Infektion mit neurologischen Symptomen zur Anschlussheilbehandlung in unserer Reha-Klinik aufgenommen. Die initial umfangreiche laborchemische und bildgebende Abkl&#xe4;rung ergab keine organische Ursache f&#xfc;r das teils apoplektiforme, komplexe Krankheitsbild, sodass bei Alltagseinschr&#xe4;nkungen und Rollatorabh&#xe4;ngigkeit die Direktverlegung in unsere Rehabilitationsklinik erfolgte.</AbstractText><AbstractText Label="UNTERSUCHUNG UND BEFUNDE">Klinisch zeigte sich ein reduzierter Allgemeinzustand bei gedr&#xfc;ckter Stimmungslage. Neurologisch imponierte eine Gangataxie, ein H&#xe4;ndetremor, eine amnestische Aphasie und verminderte Konzentrationsf&#xe4;higkeit. Eine PET/CT ergab keinen Hinweis auf einen Tumor oder eine Entz&#xfc;ndung.</AbstractText><AbstractText Label="THERAPIE UND VERLAUF">Ein multimodales Therapieprogramm, bestehend aus Physio- und Ergotherapie sowie psychologischer Mitbetreuung wurde durchgef&#xfc;hrt. Zudem wurde eine Off-Label-Therapie mit oralen Glucocorticoiden und Colchicin initiiert. Im Verlauf kam es zu einer klaren Reduktion aller Symptome mit geringem residuellen H&#xe4;ndetremor.</AbstractText><AbstractText Label="FOLGERUNG">Bei Long- und Post-Covid-Patienten mit neurologischen Symptomen unklarer Ursache kann eine Ganzk&#xf6;rper- und Hirn-FDG-PET hilfreich sein. Diese Patienten profitieren von einer systematischen Rehabilitation. Glucocorticoide und Colchicin scheinen die Symptomreduktion zu beschleunigen. Die rehabilitative Therapie sollte ambulant fortgesetzt werden.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></OtherAbstract><CoiStatement>Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>14</Day><Hour>20</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35158380</ArticleId><ArticleId IdType="doi">10.1055/a-1689-6188</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>